Last updated: April 24, 2026
INTRALIPID 20% (fat emulsion for intravenous infusion) is supplied through a defined manufacturer-and-distributor chain. The key commercial suppliers are the product’s marketing authorisation holder/manufacturer in each market, plus their national logistics partners and wholesalers. The practical supplier list below maps to how INTRALIPID 20% is actually sourced in procurement: brand manufacturer/distributor entities and the major pharma wholesalers that carry the product.
Who manufactures or markets INTRALIPID 20%?
INTRALIPID 20% is manufactured and supplied under the Fresenius Kabi brand across multiple countries, including the EU supply chain.
Brand / manufacturer (core supplier)
- Fresenius Kabi (INTRALIPID 20% fat emulsion)
Which distributors and wholesalers supply INTRALIPID 20% to hospitals?
Across hospital procurement channels, INTRALIPID 20% is typically sourced via national pharmaceutical wholesalers that hold distribution rights for the Fresenius Kabi product line and service institutional tenders.
Common supply-chain nodes (by procurement channel)
- National pharma wholesalers (institutional distribution to hospitals and clinics)
- Fresenius Kabi country affiliates (where they act as the local marketing/distribution entity)
- Tender distributors in institutional markets (third-party distributors contracted into hospital procurement)
What should be treated as “the supplier” in procurement workflows?
For contracting and ordering, buyers typically treat the supplier as one of the following:
- Marketing authorisation holder / manufacturer (commercial responsibility and product origin)
- Local marketing/distribution company (invoice issuer in-country)
- Wholesaler (who physically ships to the hospital and holds stock)
INTRALIPID 20% sourcing matrix (what you contract for)
| Procurement target |
Supplier type |
Typical role |
Practical proof point in tenders |
| Bottle/pack origin |
Fresenius Kabi manufacturing entity |
Manufactures INTRALIPID 20% emulsion |
Listed as manufacturer on pack labeling / SmPC |
| In-country distribution |
Fresenius Kabi country affiliate |
Orders, distribution, local labeling |
Listed on national product registration and local package information |
| Stock-to-hospital shipment |
National wholesaler |
Warehousing and delivery |
Listed as supply source on hospital tender awards / pharmacy supply catalogs |
What supplier set is “most relevant” for direct purchasing?
Direct hospital and clinic purchasing
- Use the in-country wholesaler that is awarded in your tender geography.
- Confirm the manufacturer line item in the procurement spec matches Fresenius Kabi for INTRALIPID 20%.
Government and large health-system tenders
- Contracts usually name:
- Local distributor/wholesaler (award counterparty), and
- Manufacturer (Fresenius Kabi) via product specification.
Product registration and labeling anchors (for supplier verification)
When specifying INTRALIPID 20%, tender documents and product registration records normally anchor suppliers to the manufacturer and local marketing authorisation holder, which is how procurement teams validate that the delivered product is the named brand and concentration.
- Active product: INTRALIPID 20% (fat emulsion intravenous)
- Manufacturer / brand owner in supply chain: Fresenius Kabi (core supplier)
Source: INTRALIPID product information (SmPC/labeling) distributed by Fresenius Kabi.
Key Takeaways
- The core manufacturer/supplier for INTRALIPID 20% is Fresenius Kabi.
- Hospital purchasing typically routes through national pharma wholesalers that stock and deliver the product under Fresenius Kabi’s brand supply chain.
- In procurement, the “supplier” depends on contract structure: manufacturer (Fresenius Kabi), local Fresenius Kabi distribution entity, or the awarded wholesaler shipping to the site.
FAQs
1) Who is the primary supplier for INTRALIPID 20%?
Fresenius Kabi is the core manufacturer/brand supplier for INTRALIPID 20% through the product’s official packaging and product information.
2) Are wholesalers considered suppliers for INTRALIPID 20% orders?
Yes. In hospital and clinic procurement, the wholesaler is typically the operational supplier that invoices and ships, while Fresenius Kabi is the product manufacturer anchor.
3) How do you confirm the supplier identity in tenders?
Match the specification to the brand product and concentration, and verify the manufacturer listed on product labeling/SmPC aligns with Fresenius Kabi.
4) Does INTRALIPID 20% come from one global distribution channel?
No. Distribution is typically country-specific, using local Fresenius Kabi entities and national wholesalers.
5) What supplier name should be listed in an institutional purchase order?
List the invoice/shipping counterparty as the supplier (usually a national wholesaler), and ensure the product line references INTRALIPID 20% with Fresenius Kabi as the manufacturer anchor.
References
[1] Fresenius Kabi. INTRALIPID 20% emulsion for infusion: Summary of Product Characteristics (SmPC) / product information. Fresenius Kabi product documentation.
